Hacker News Reader

This site also has an article wistfully praising Remdesivir, a proprietary drug with far less evidence than HCQ. I think money might be talking here.

View on HN

A proprietary drug whose maker has said they will donate all 1.5 million doses that they currently have. That's more than they'll be able to produce over the next year (1 million) even after greatly increasing that production capacity.

The goal is more than 1 million treatment courses (10 million doses) by the end of this year.

https://www.gilead.com/stories/articles/an-update-on-covid-1...

Ah, I had misread that.

That statement didn't clearly say whether they were going to donate those that they haven't produced yet. If they aren't donating that, this donation is like a ~10% discount (compared to the ~66% discount I had originally interpreted it in that case).

A lot of people just don't believe an old, boring drug cocktail can prove effective against a new disease.

Reply on news.ycombinator.com